| Literature DB >> 35808255 |
Emiliano Martínez-Periñán1, Marcos Martínez-Fernández2, José L Segura2, Encarnación Lorenzo1,3,4.
Abstract
Covalent organic frameworks (COFs) are defined as crystalline organic polymers with programmable topological architectures using properly predesigned building blocks precursors. Since the development of the first COF in 2005, many works are emerging using this kind of material for different applications, such as the development of electrochemical sensors and biosensors. COF shows superb characteristics, such as tuneable pore size and structure, permanent porosity, high surface area, thermal stability, and low density. Apart from these special properties, COF's electrochemical behaviour can be modulated using electroactive building blocks. Furthermore, the great variety of functional groups that can be inserted in their structures makes them interesting materials to be conjugated with biological recognition elements, such as antibodies, enzymes, DNA probe, aptamer, etc. Moreover, the possibility of linking them with other special nanomaterials opens a wide range of possibilities to develop new electrochemical sensors and biosensors.Entities:
Keywords: COF; electrochemical biosensors; electrochemical sensors
Mesh:
Substances:
Year: 2022 PMID: 35808255 PMCID: PMC9268951 DOI: 10.3390/s22134758
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.847
Figure 1(A) Examples of COFs topology diagrams. (B) Examples of linkages commonly used for the synthesis of COFs (from left to right: boronate ester, imine, imide, and triazine. (C) Examples of arrangements of COF’s networks. (D) List of linkers named in this review.
Figure 2Schematic illustration of a glassy carbon electrode modified with a magnetic Fe nanocomposite used for the simultaneous detection of PNP and ONP. Reprinted with permission from Ref. [85]. Copyright 2019 Elsevier.
Figure 3Schematic representation for the production of WP6@Ag (A); synthetic route to produce the COF and assembly of WP6-modified Ag nanoparticles on the surface of COF and its application for electrochemical sensing of PQ (B). Reprinted with permission from Ref. [58]. Copyright 2019 American Chemical Society.
Figure 4Schematic illustration of MWCNTs@COF-TFP-BTH showing possible adsorption sites for Hg2+ and nitrofural. Reprinted with permission from Ref. [109]. Copyright 2022 Elsevier.
Figure 5Schematic illustration of preparation and application of enzymes@COF microcapsule. Reprinted with permission from Ref. [75]. Copyright 2021 Elsevier.
Figure 6Synthesis of the Fe nanohybrid by H. Liang et al. [114] (A) and assembly of the immunosensor for the PSA and signal conversion strategy (B). Reprinted with permission from Ref. [114]. Copyright 2019 Elsevier.
Figure 7(a) Preparation of the Cu-MOF@CuPc-TA-COF Hybrid Material by the Miao Du’s research group [119] and (b) Construction Procedure of the HIV-1 DNA Biosensor Based on the Cu-MOF@CuPc-TA-COF Hybrid. Reprinted with permission from Ref. [119]. Copyright 2021 American Chemical Society.
Figure 8(a) Scheme of the synthesis of Py-M-COF. (b) Scheme of electrochemical detection of ENR and AMP using the Py-M-COF-based aptasensors. Reprinted with permission from Ref. [125]. Copyright 2019 Elsevier.
Examples of COFs application in different samples.
| COF | Modifier | Analyte | Sample | Electrode | LOD | Linear Range | Sensitivity | Ref. |
|---|---|---|---|---|---|---|---|---|
| DQTP-COF | β-ketoenamine | Bisphenol A, and S | Food packages | Graphite | 0.15 and | 0.5–30 and 0.5–30 µM | 0.239 and 0.150 µA/µM | [ |
| TPA-COF | Composite Carbon Black | Dopamine | Medical injections | Glassy Carbon | 0.17 µM | 20–1000 µM | 0.023 µA/µM | [ |
| TAPB-DMTP-COF@PANI | polyanyline | Acetaminophen | Tablets, human blood, serum and urine | Glassy Carbon | 0.032 µM | 0.10–500 µM | 0.1229 µA/µM | [ |
| Fe3O4@AT-COF | Fe3O4 | Lake and tap water | Magnetic beads | 0.2278 and 0.5925 μM | 10–3000 and 10–3000 µM | 0.7588 and 0.7799 µA/µM | [ | |
| FeTAPP-TA-COF | Composite graphene aerogel | NO | Complex biological system | Glassy carbon | 0.030 μM | 0.18–400 μM | 8.8 μA/μM·cm2 | [ |
| MA-TP-COF | β-Ketoamine | Cd2+, Cu2+, Pb2+, Hg2+ and Zn2+ | Drinking water | Glassy Carbon | 0.922, 0.450, 0.309, 0.208 and 0.526 nM | - | 17.8, 36.6, 53.2, 79.1 and 31.3 μA/μM cm2 | [ |
| DTPA-TFB-COF | kenaf stem-derived macroporous carbon | Cd2+, Pb2+, Cu2+ and Hg2+ | Soil and sewage | 12.3, 11.8, 18.6 and 21.4 nM | 0.0369–18.0, 0.0356–19.0, 0.0536–19.0, and 0.0503–18.0 µM | 1337.4, 1389.0, 886.2 and 770.0 μA/μM cm2 | [ | |
| GOD/DMFc/PA-TFB-COF/CFMEs | DMFc and GOD | Glucose | Rats’ brains | Carbon fibre microelectrode | 0.36 µM | 1.08 μM to 8.5 mM | 46.55 mV/mM cm2 | [ |
| enzyme@ZIF-8@COF | GOD, HRP, AChE | Glucose, H2O2 and malathion | Glassy Carbon | 0.85 μM, 2.81 nM, 3.0 × 10−13 g/L | 2.83 μM–8.0 mM, 9.53 nM–7.0 μM, 10−12 g/L–10−8 g/L | - | [ | |
| COFs-AuNPs | AuNPs, Capture antiKIM-1 | KIM-1 | Plasma samples | Glassy Carbon | 2.00 fg/mL | 0.01–50.00 pg/mL | 1.8981 µA·mL/pg | [ |
| AuPt@MnO2@COF | AuNPs, PSA affinity peptide | PSA | Human serum | 16.7 fg/mL | 0.00005–10 ng/mL | 2.237 µA/log (ng/mL) | [ | |
| TP-PANO2-COF | AuNPs, CYFRA21-1 antibodies | CYFRA21-1 | Human serum | 0.1 pg/mL | 0.5–1.0 × 104 pg/mL | 6.3 µA/log (pg/mL) | [ | |
| Cu-MOF@Cu-PcTA-COF | Cu-MOF, HIV-1 DNA probe strands | HIV-1 DNA | Human serum | Glassy carbon | 0.07 fM | 1 fM to 1 nM | - | [ |
|
| ||||||||
| 1,3,5-triformylphloroglucinol ( | ||||||||
| 1,3,5-tris(4-aminophenyl) benzene ( | ||||||||
| 5,10,15,20-tetrakis [(4-aminophenyl) porphinato]-iron ( | ||||||||
| 2,4,6-triformylphloroglucinol and melamine ( | ||||||||
| 1,4-benzenedithiol-2,5-diamino-hydrochloride ( | ||||||||
| 1,3,5-Triformylbenzene ( | ||||||||
| 1,3,5-tris( | ||||||||
| Triformylphloroglucinol and 2-nitrobenzene-1,4-diamine ( | ||||||||
| Copper-phthalocyaninetetra-amine ( | ||||||||